SpyGlass Drug-Eluting Pads

Jason Bacharach, MD

Show Description +

Jason Bacharach, MD, shares insights into a novel drug-delivery platform from SpyGlass Technology, which he recently discussed at the American Glaucoma Society annual meeting. The platform delivers bimatoprost over a period of years via pads placed at the haptic-optic junction during IOL implantation. He reviews data showing demonstrated IOP lowering and no adverse events.

Posted: 3/06/2025

Keywords:

Glaucoma

•

AGS

Up Next

Name: SpyGlass Drug-Eluting Pads
Uploaded: 2025-03-06T18:15:28+00:00
Description: Jason Bacharach, MD, shares insights into a novel drug-delivery platform from SpyGlass Technology, which he recently discussed at the American Glaucoma Society annual meeting. The platform delivers bimatoprost over a period of years via pads placed at the haptic-optic junction during IOL implantation. He reviews data showing demonstrated IOP lowering and no adverse events.